(Alliance News) - Stock prices in London were weaker on Wednesday, with some pre-Federal Reserve decision nerves and geopolitical tensions hurting sentiment. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive high-level results from its latest trial evaluating Enhertu in patients with high-risk, locally advanced HER2-positive early-stage breast cancer. Read More
(Alliance News) - London's FTSE 100 gave back a fraction of its recent progress early Wednesday, despite some optimism on the tariff front, ahead of a US interest rate decision later. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said Calquence plus chemoimmunotherapy has been approved in the European Union for previously untreated mantle cell lymphoma in adults. Read More
(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, kicking off the week following an extended bank holiday weekend, as Germany prepares to swear in its new chancellor and UK consumer confidence hits a new low. Read More
(Alliance News) - AstraZeneca PLC on Friday reported that its triple-combination asthma treatment Breztri Aerosphere met all primary endpoints in two late-stage clinical trials, raising the potential to improve treatment options for patients whose condition is not controlled by current therapies. Read More
(Alliance News) - The FTSE 100 edged higher on Thursday, extending its best winning run since 2017, supported by tech-inspired gains on Wall Street. Read More
(Alliance News) - Stock prices in London were mostly higher at midday on Tuesday, with concerns voiced following Spain and Portugal's major power cut that a similar outage could hit UK infrastructure. Read More
(Alliance News) - AstraZeneca PLC on Monday said growth has continued into 2025, with the chief executive officer saying the pharmaceutical maker has "entered an unprecedented catalyst-rich period for our company". Read More
(Alliance News) - Hutchmed China Ltd on Tuesday said it has completed patient enrolment for a phase II registration trial of savolitinib, targeting gastric cancer in patients with MET gene amplification. Read More
(Alliance News) - The FTSE 100 resumed its downward path on Wednesday, as China hit back against US tariffs, while a volatile bond market added to the nervous mood. Read More
(Alliance News) - London stocks remained in the red at midday on Wednesday, as US tariffs continue to wreak havoc on global markets, and British gilt yields reach their highest point in more than 25 years. Read More
(Alliance News) - London's FTSE 100 is called to open lower on Wednesday following the announcement of new further US tariffs on China, and global markets brace themselves for further turmoil. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Read More
(Alliance News) - The bloodbath in global equities worsened on Monday, in a roller-coaster end to the day, as Donald Trump warned China he would raise tariffs further and doubled-down on trade policy. Read More